|
|
||
|---|---|---|
|
January
January; 39 (1): 1 - 111 |
February
February; 39 (2): 115 - 296 |
March
March; 39 (3): 299 - 439 |
|
April
April; 39 (4): 441 - 558 |
May
May; 39 (5): 559 - 672 Supplement: Quinupristin/dalfopristin - update on the first injectable streptogramin |
June
June; 39 (6): 673 - 842b Supplement: Trovafloxacin: a novel extended spectrum quinolone |
|
July
July; 40 (1): 1 - 146 |
August
August; 40 (2): 149 - 309 |
September
September; 40 (3): 311 - 461 |
|
October
October; 40 (4): 463 - 608 |
November
November; 40 (5): 611 - 746 |
December
December; 40 (6): 749 - 913 Supplement: Grepafloxacin: focus on respiratory infections Supplement: The clinical evaluation of antiviral agents |